KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables - Net (2018 - 2025)

Historic Receivables - Net for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $50.1 million.

  • Twist Bioscience's Receivables - Net rose 2733.56% to $50.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.1 million, marking a year-over-year increase of 2733.56%. This contributed to the annual value of $57.0 million for FY2025, which is 6336.42% up from last year.
  • Per Twist Bioscience's latest filing, its Receivables - Net stood at $50.1 million for Q4 2025, which was up 2733.56% from $57.0 million recorded in Q3 2025.
  • Twist Bioscience's Receivables - Net's 5-year high stood at $57.0 million during Q3 2025, with a 5-year trough of $27.3 million in Q1 2021.
  • For the 5-year period, Twist Bioscience's Receivables - Net averaged around $40.4 million, with its median value being $40.3 million (2022).
  • As far as peak fluctuations go, Twist Bioscience's Receivables - Net soared by 11065.41% in 2021, and later crashed by 2530.56% in 2024.
  • Over the past 5 years, Twist Bioscience's Receivables - Net (Quarter) stood at $32.9 million in 2021, then surged by 35.18% to $44.4 million in 2022, then dropped by 20.44% to $35.4 million in 2023, then grew by 11.2% to $39.3 million in 2024, then rose by 27.34% to $50.1 million in 2025.
  • Its last three reported values are $50.1 million in Q4 2025, $57.0 million for Q3 2025, and $49.9 million during Q2 2025.